Navigation Links
New therapy for fragile X chromosome syndrome discovered
Date:4/10/2013

utical drugs that block the function of the cerebral endocannabinoid system may well be a new strategy for treating patients with fragile X chromosome syndrome.

Rimonabant pharmaceutical drug has been on the market for some time "for the treatment of obesity", explained Ms Mato. "Then, however, it was used in much higher doses and these high dosages gave rise to certain psychiatric problems, and this is why it was taken off the market". Nonetheless, it involves a drug which "has been used a lot in preclinical research into the endocannabinoid system, and its action mechanism is very well established".

The next step, Ms Mato pointed out, should be "to better characterise the action mechanism of this treatment, and test the various dosages to see what would be the optimum one to normalize the deficit. And the following stage would be the clinical trials. In fact, we believe this would be relatively feasible, because as it has already been marketed, all that preclinical stage regarding toxicity of the drug for humans has been undertaken, and it is a relatively safe pharmaceutical drug".

Although Ms Mato considers it to be a great advance that it has been shown in animal models that "the cognitive deficit caused by the disease has been normalised to a certain extent", she is aware that it could be that "the clinical trials do not produce such good results, as it is common for this to happen when developing therapies for psychiatric disorders".


'/>"/>

Contact: Oihane Lakar Iraizoz
o.lakar@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Page: 1 2

Related biology news :

1. Ludwig presents advancements in immunotherapy and epigenetics at the American Association for Cancer Research Annual Meeting
2. Ludwig advancements in immunotherapy and epigenetics top scientific program at AACR
3. Research advances therapy to protect against dengue virus
4. St. Jude Childrens Research Hospital announces issuance of US patent for cancer therapy
5. Research supports promise of cell therapy for bowel disease
6. Novel combination therapy shuts down escape route, killing glioblastoma tumor cells
7. Local therapy followed by treatment with EGFR TKI is well tolerated
8. New therapy for heart failure may enhance bodys stem cell response at cardiovascular injury site
9. Cell therapy a little more concrete thanks to VIB research
10. Preclinical study shows potential of new technologies to detect response to cancer therapy earlier
11. Novel coronavirus well-adapted to humans, susceptible to immunotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 31 de julho de 2015 A 10 ... ) será realizada pela BGI de 22-25 de outubro de ... A conferência está celebrando seu 10 o. ... ICG se tornou uma das reuniões mais influentes do ... científicos mais dinâmicos, entusiastas e prazerosos. ...
(Date:7/31/2015)... 31. Juli 2015 Die 10. internationale Konferenz zu ... veranstaltet und findet vom 22. bis 25. Oktober ... statt. Die Konferenz feiert in ... 2006 ist die ICG weltweit zu einem der ... ist eines der dynamischsten, enthusiastischsten und angenehmsten wissenschaftlichen ...
(Date:7/30/2015)... 2015 Cellecta, Inc., a U.S.-based provider ... and biomarker discovery, announced the release of its ... all human protein coding genes. CRISPR technology enables ... gene,s function. Cellecta,s new Human Whole Genome CRISPR ... so that researchers can investigate in a single ...
Breaking Biology News(10 mins):A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2
... Techniques used by researchers from the Department of Energy,s ... and its resident bacteria could accelerate efforts to understand more ... In a paper published in the Proceedings of ... analyzed the proteins found in a marine worm known as ...
... The rapid shift from nomadic life to modern-day ... to significant indoor air quality risks that can lead ... the University of North Carolina at Chapel Hill. ... agencies have not performed the research required to pinpoint ...
... University of California, San Diego Jacobs School of ... Challenges Explorations winner, an initiative funded by the ... Todd Coleman, in collaboration with Materials Science and ... of Illinois at Urbana-Champaign, will pursue an innovative ...
Cached Biology News:ORNL protein analysis investigates marine worm community 2Culturally sensitive research in United Arab Emirates pinpoints indoor air quality risks 2Tattoo-like devices for wireless pregnancy monitoring 2Tattoo-like devices for wireless pregnancy monitoring 3
(Date:8/3/2015)... MARIETTA, Ga. , Aug. 3, 2015  MiMedx ... medicine company utilizing human amniotic tissue and patent-protected processes ... the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic ... will present at the 35 th Annual Canaccord|Genuity ...  Parker H. "Pete" Petit, Chairman and CEO, William ...
(Date:8/3/2015)... ... , ... Nine field days to promote practices that improve soil health will ... Health Partnership , the field days will demonstrate how changing certain practices, such as ... income. , Brent Bible has practiced no-till farming and planted cover crops on his ...
(Date:8/3/2015)... --  Intrexon Corporation (NYSE: XON ) today ... 2015 financial results after the market closes on Monday, ... a conference call at 5:30 PM ET to discuss ... The conference call may be accessed by dialing ... join the "Intrexon Corporation Call."  Participants may also access ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... pumps to its comprehensive line of analytical laboratory equipment. With optimized features, such ... pumps provide a chemically resistant and maintenance-free solution for a broad range of ...
Breaking Biology Technology:MiMedx To Present At 35th Annual Canaccord|Genuity Growth Conference 2Soil Health Field Days Kick Off Throughout Midwest 2Soil Health Field Days Kick Off Throughout Midwest 3Intrexon to Announce First Half and Second Quarter 2015 Financial Results and Host Conference Call on August 10th 2Sterlitech Launches New Line of Vacuum Pumps 2
... Fully Automated, Portable Solution for In-Clinic and Out-Reach Influenza ... ... England, October 3 Enigma Diagnostics, the,life sciences company developing rapid ... European Commission,Framework 7 programme to the RANGER consortium. The award will ...
... progress research from academic settings to ... and therapeutics -, BOSTON, Oct. 2 The ... broader than most might think,including not only the longer-term ... and test therapeutics for,multiple diseases, including diabetes, according to ...
... Foundation for,Biomedical Research (FBR) congratulates Congress for today ... civilian honor it can bestow, the,Congressional Gold Medal. ... improved the health of millions of American citizens ... a surgeon, inventor, educator and,medical statesman make him ...
Cached Biology Technology:Enigma Diagnostics Announces a European Commission Award of EUR3 Million to Fund the Development of a Point of Care Platform for the Rapid Diagnosis of Influenza Infections 2Stem Cell Science Holds Opportunities as Important Tool for Diabetes Research Beyond Cell-Based Treatments 2Stem Cell Science Holds Opportunities as Important Tool for Diabetes Research Beyond Cell-Based Treatments 3Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal 2
... to histochemically detect specific ... pH in cultured cells ... specific marker is only ... (not found in presenescent/quiescent/immortal ...
Recombinant Mouse LIGHT/TNFSF14...
Viral CMV UL146/vCXC1 Biotinylated Affinity Purified PAb...
Request Info...
Biology Products: